Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced its audited final results for the 12 months ended 31 December 2021. Financial highlights ·       Record revenues of £39.0m (2020: £22.2m) achieved representing 76% growth ·       £9m improvement … Continue reading Open Orphan report record revenues and EBITDA-profitability and significant operational progress